5 results match your criteria: "Hospital of Charleville-Mezieres[Affiliation]"

: To demonstrate that a BRASS score≥ 3 at admission of intubated, ventilated and sedated patients is predictive of mortality: we have realized an Observational prospective multicenter study.All Major patients without neurological history, admitted to ICU for a non-neurological cause, sedated and admitted under mechanical ventilation were included.: One hundred and ten patients were included, the BRASS score as well as the FOUR and RASS scores were collected.

View Article and Find Full Text PDF

Predominance of G9P[8] rotavirus strains throughout France, 2014-2017.

Clin Microbiol Infect

June 2018

National Reference Centre for Gastroenteritis Viruses, Laboratory of Biology and Pathology, University Hospital of Dijon, France; UMR PAM A 02.102 Procédés Alimentaires et Microbiologiques, Université de Bourgogne Franche-Comté/AgroSup Dijon, France; French Rotavirus Network, France. Electronic address:

Objectives: Group A rotavirus is a major cause of acute gastroenteritis in young children worldwide. A prospective surveillance network has been set up in France to investigate rotavirus infections and to detect the emergence of potentially epidemic strains.

Methods: From 2014 to 2017, rotavirus-positive stool samples were collected from 2394 children under 5 years old attending the paediatric emergency units of 13 large hospitals.

View Article and Find Full Text PDF

Seven commercial immunochromatographic assays intended for the detection of group A rotavirus antigens in human stool samples were evaluated. These assays showed similar levels of diagnostic accuracy and were suitable for the detection of rotavirus in patients with acute gastroenteritis but missed some asymptomatic rotavirus shedding identified by real-time reverse transcription-PCR.

View Article and Find Full Text PDF

Background: Chemoradiotherapy (CHRT) is often advocated for locally-advanced biliary tract cancer (LABTC). However there was not comparative study with chemotherapy alone (CH).

Patients And Methods: Patients with hilar or extrahepatic non-metastatic, LABTC could be included in this phase II trial.

View Article and Find Full Text PDF